There is no ”one size fits all” approach for biopharmaceutical manufacturing facilities. Every site is different and can come with its own set of constraints. And that can mean that integrating a filtration system into a customer’s site isn’t always straightforward. Let’s look at a recent project for a European biopharmaceutical manufacturer.
The manufacturer had invested in a brand-new facility and were interested in filtration systems for the final step in the downstream process before bottling. But unusually, the design of the suites were such that drug product, buffer and WFI tanks were housed on the floor above where the filtration processes were to be carried out. This layout may have been shaped by the manufacturer’s intention to use hydrostatic pressure to minimize product losses. However, this resulted in a challenge of how to design the systems to accommodate to this height difference to connect to the tank outlets.
The space dedicated to the filtration system on each process line was constrained due to the suite layout and other equipment in the proximity – which limited the space available to a small footprint.
The solution needed to integrate with the process fluid tanks and the customers pre-existing filling system, which further increased the complexity to enable communication with multiple systems. Faced with design implications of a limited footprint and structural considerations, Parker was able to adapt its standard automation offerings to develop a bespoke solution tailored to a customer’s uniquely designed facility.
However, this was just the start of the journey. A strong working partnership was developed as Parker’s team worked closely with the customer during the design phase. Regular meetings and reviews of hardware and software designs kept the project on track.
Inclusion of PUPSIT (pre-use post sterilization integrity testing) capabilities was a key factor within the specification of the system based on the EU Annex 1 requirement. Parker was able to provide an automated solution which was integrated into the system as part of the process sequence.
Overall, the project demonstrated Parker’s agility and flexibility in creating bespoke solutions for the biopharmaceutical manufacturing sector. We employed our technical expertise and accessibility to develop a synergistic approach to provide a modular solution and overcome the challenges that the customer presented.